Mcnor-PG Tablet is a combination medication containing Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, formulated for the management of neuropathic pain and associated conditions. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channels to reduce neurotransmitter release, thereby alleviating nerve pain. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, contributing to pain relief and mood stabilization. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair, promoting neuronal health. This combination is particularly effective in treating diabetic neuropathy, postherpetic neuralgia, and other peripheral neuropathies where both analgesic and neurotrophic effects are desired. Mcnor-PG Tablet is indicated for patients requiring multimodal therapy to improve pain control and nerve function. It should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common side effects may include dizziness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiovascular disease, or a history of seizures. Regular monitoring is recommended to assess therapeutic efficacy and detect potential adverse effects. Mcnor-PG Tablet offers a comprehensive approach to neuropathic pain management by combining analgesic, antidepressant, and neurotrophic agents in a single formulation.